MTOR and autoimmune lymphoproliferative syndrome: These data have been further validated by other studies demonstrating that the pathognomonic DNT cells, as well as a subset of CD4 and CD8 T cells in patients with ALPS, are highly proliferativein vivo associated with a hyperactive mTOR pathway19.